Lv4
440 积分 2023-08-09 加入
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
26天前
已完结
Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database
26天前
已完结
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
26天前
已完结
Silver Jubilee of HER2 targeting: a clinical success in breast cancer
1个月前
已完结
Drug-induced immune hemolytic anemia: the last 30 years of changes
1个月前
已完结
High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS database
1个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines
1个月前
已完结
Pharmacological evaluation of the use of dexrazoxane in preventing anthracycline induced cardiotoxicity in breast cancer
1个月前
已完结
皖公网安备34019202002308
